chrisvoncsefalvay/vaers-outcomes huggingface dataset:
adult received a pediatric dose; adult received a pediatric dose; This case was reported by a nurse via call center representative and described the occurrence of underdose in a 60-year-old male patient who received HBV (Engerix B pediatric) (batch number 95EJ7, expiry date 6th February 2023) for prophylaxis.   On 18th January 2023, the patient received Engerix B pediatric .5 ml. On 18th January 2023, unknown after receiving Engerix B pediatric, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.   Additional Information: GSK receipt date: 18-Jan-2023 Reporter's comment: The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up. Additional supportive information: An adult patient received a pediatric dose of Engerix-B, which led to underdose and adult use of a child product.
very itchy in those portions; hot all over, mostly the face and top of legs; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (very itchy in those portions) and FEELING HOT (hot all over, mostly the face and top of legs) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (very itchy in those portions) and FEELING HOT (hot all over, mostly the face and top of legs). The patient was treated with CEFALEXIN (KEFLEX [CEFALEXIN]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PRURITUS (very itchy in those portions) and FEELING HOT (hot all over, mostly the face and top of legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Additional information received
Numbness in feet.  Balance compromised. SLEEP DEPRIVATION: Inability to fall back to sleep after trip to restroom each evening in the middle of the night, owing to the requirement to become so fully awake and engaged so as not to fall .
Shortly after receiving the 4th dose, I experienced quite a but of tiredness and soreness. After that resolved I noticed a sudden onset of tinnitus in my right ear. I have always suffered from tinnitus but the issue was different. My doctor recommended I see an ENT who suggested that I use Flonase to open my  Eustachian tube based on the hypothesis that I had an infection in my middle ear. This did not help at all. I went to another ENT which was not helpful. Taking the Flonase has eliminated my tongues ability to detect sweet and sour taste. This has been quite devastating to me as I enjoy the taste of food. I still have the remaining 3 taste buds. My hope is that my sense of taste will recuperate as my sense of smell is unaffected. I am still seeing my primary care physician but losing hope as they are not able to determine what caused the tinnitus and loss of taste. On April 25 was when I first noticed a change in my sense of taste and nausea. Stomach pains began on April 28. My doctor diagnosed me with GERD. The nausea went away but the other issues remain.
Very bad itching all over bodyIt happened as soon as patient got out of the facility; This is a spontaneous report from contactable consumer (patient himself). A 35-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0180), via an unspecified route of administration, administered in arm right on 26May2021 14:00 (age at the vaccination was 35-year-old) as dose 2, single for covid-19 immunisation. Medical history included diabetes mellitus from an unknown date and unknown if ongoing. The patient had no known allergies Penicillin and latex. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. Historical vaccine included, the patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number: EW0173), via unspecified route of administration, administered in arm right on 05May2021 14:00 (age at the vaccination was 35-year-old) as dose 1, single for covid-19 immunisation. The patient experienced very bad itching all over body it happened as soon as patient got out of the facility on 26May2021 15:00. Timeframe between vaccination and starting of the event was 1 hour. Since the vaccination, patient was not tested for COVID-19. Zyretc treatment was received in response to the events. The outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
I had chills through out my whole body for about 3 1/2 hours, I went to bed without supper and finally got warmed up. I had no other adverse effects..The next day i also had no more difficulty.
A mild itching and swelling of my throat that lasted about an hour. This reaction happened within five minutes of getting the shot.
Within a few hours got stiff and sore but about 4pm right arm completely stopped working--I couldn't lift it up. Left arm was sore but nothing like the right. Could barely drive home with one arm. Took ALEVE at night and then ADVIL to supplement it but not enough to help. Spine, neck, shoulders started aching and cramped up. Used heating pad and sleeping pill, but in severe pain--pain at level 9 during the evening. Back, shoulders, neck hurt severely like beat with a rubber hose. Doing the same daily work but feel like have been mugged--feel so overworked. Has been taking ALEVE twice a day as per doctor's instructions with no relief. All joints hurt like if had severe arthritis. Called the doctor the next day and contacted them on several occasions since to provide update and request additional advice.  Went to doctor office on 3/13 and got some testing done.
Pain in neck, shoulder and right arm. It was also itchy. The next day, the pain continues, hot and swollen. Pain scale is 9 (1-10). On Sunday, the injection site became red, swollen, inflamed, hot, spread about 4-5 inches. Monday, patient reported to the pharmacy. Will see MD on 09/29.
Pt reports getting persistent headaches approximately 5 days post receiving ZOSTAVAX shot. She is aware this is side effect, but still getting.
L axillary redness with approximately 10 cm red streaky cephalad L anterior shoulder.
A report received from a healthcare professional on 10/29/2003, concerned a 7 year old vaccinee of unknown sex, who received a sub-optimal dose of Fluvirin on 10/25/2003. On 25 October 2003, a 7 year old vaccinee received 0.25ml Fluvirin, instead of 0.5ml.  There were no adverse reactions reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
vomiting, chills and abnormal vs began on 11/14/21 sent to ER and admitted for Sepsis, Pneumonia, A-fib, bilateral pulmonary embolism, and bilateral DVT.
Within a day or 2 my lower legs went numb. It has spread upwards to my thighs and abdomen.  My dr referred me to a neurologist, who did an emg, which is normal. Since then, experiencing mor numbness, pain  and lameness. I have also had a lazy eye, double vision, and extreme fatigue, for which I?ve had to miss a lot of work for. I have I full brain and spine mri this Friday, ordered by my neurologist. He also ordered a lot of blood work, everything has been normal.
Patient c/o numbness, tingling & inability to grasp/grip with bilateral hands. Has sensation to hands but states "it feels like my hands are asleep." These symptoms started roughly 2 1/2 to 3 hours post vaccination.
Sedation, Myalgia, Fever, neuropathy flare up bilateral arms. Metallic taste then burning mouth syndrome Narrative:
C/o itching in left upper arm last night according to father. Upper arm red, warm and slightly swollen. No treatment per father enc to apply ice and give an antihistamine for age.
Information has been received from a healthcare worker and a physician concerning an 11 year old white female with no pertinent medical history and no known drug reactions/allergies who on 18-AUG-1997 was vaccinated with the first dose of VARIVAX (Merck) (LOT # 623125/0546E).  On 14-AUG-2007 the patient was vaccinated with the second dose of VARIVAX (MERCK).  Concomitant vaccination on 14-AUG-2007 included a dose of GARDASIL (MSD) and a dose of HEPATITIS A virus vaccine (unspecified) (manufacturer unknown).  It was reported that the patient received two doses of VARIVAX (Merck) "by mistake".  There was no illness at time of vaccination and no rash was occurred at the site of injection within 42 days of the vaccination.  On 08-JUL-2008 the patient developed shingles.  Multiple cluster of vesicular was erythematic painful base along left shoulder and around hand with pain (the child was crying).  On 22-JUL-2008, the patient recovered from shingles.  No medical attention was sought.  Additional information is not expected.
Fatigue, body ache, chills, nausea, headache. Resolved.
Fever, Cough, Rash covering torso and face, swollen and watery eyes.
08/04/04: Vaccine. 08/05/04-08/06/04: Stuffiness, sore throat. 08/07/04: Sore throat, rash on buttocks. 08/08/04: Throat soreness, intense.
Injection site pain; Tired; Headache; Muscle pain; Chills; Feeling unwell; Low back pain; Neck pain; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er 8733) via an unspecified route of administration in the left arm on 05May2021 at 08:30 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Patient had no medical history. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6207) via an unspecified route of administration in the left arm on 14Apr2021 at 08:45 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021 at 08:45 the patient experienced injection site pain, tired, headache, muscle pain, chills, feeling unwell, low back pain and neck pain. The clinical outcome of the events  injection site pain, tired, headache, muscle pain, chills, feeling unwell, low back pain and neck pain was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
got the flu; Initial information received on 25-Dec-2022 regarding an unsolicited valid social media non-serious case from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who got the flu after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.    On an unknown date, the patient received suspect influenza vaccine produced by unknown manufacturer at an unknown dose (lot number, expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination (Immunisation).  On an unknown date the patient developed a non-serious got the flu (influenza) (unknown latency) following the administration of influenza vaccine.  It is unknown if there were lab data/results available.  Action taken: Not applicable.  Corrective treatment: Not reported.  Outcome: Unknown for the event got the flu.
Mother calls and reports swollen lymph nodes in right neck the morning following vaccination. Over time, lymph nodes did improve. No fever or other concerns.
3-4 hours - Flu like symptoms, body aches 12-14 hours -  severe nausea and seizure
Temp of 102-103 8 days after dose and lasted 2 days. Then developed puritic small macules with few vesicles over much of body.
Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.). On an unknown date, the patient PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided. It was reported that the patient took half dose booster. Vial was initially stored in the refrigerator on 31-Jan-2022. It was reported that the vial did not undergo any temperature excursions. Treatment information was not provided.
Information has been received from a registered nurse concerning a 74 year old female patient with diabetes and no allergies who on 04-NOV-2009 was vaccinated with a 0.5 ml second dose of PNEUMOVAX 23 (Lot number 665300/1314Y) IM in right arm. The patient received the first dose of PNEUMOVAX 23 in the past (unknown date). Concomitant therapy included "a lot of medications". On 05-NOV-2009 the patient's right arm was red and swollen. The size of the area was 7X10 inches of redness and swelling. At the time of the report the patient was recovering. The patient sought medical attention by an office visit on 06-NOV-2009. The patient did not have any lab diagnostics studies performed. Additional information has been requested.
I have seen the slightest symptoms since the begining of her chart. Constant sinus infections accompained by a wheeze and cough. She also is having some various allergies to food. There was some dental abnormalities no enamel over the teeth. I noticed some headaches with a little hoarseness. I have also been concerned that her reflex system seems slower. Stomach aches?  2/5/09 Received PCP medical records of 4/7/2009-1/15/2009. FINAL DX: Records reveal patient in foster care & experienced frequent URIs & dx w/probable asthma w/nocturnal cough & wheezing.  12/13/08 had RSV bronchiolitis, exacerbation of asthma & OM.
2 days after shot 1 on March 19, 2021,  I began experiencing very bad clogged ducts. I am a lactating/breastfeeding mother. They mostly occurred on the left breast, closest to the injection site.  I had 1-2 bad clogs a week that would take 2-3 days to resolve, and this lasted for 5 weeks until I received the second Covid-19 dose. No particular treatment helped (I tried all recommended methods to relieve a clogged duct), just time and continuous breastfeeding.  2 days after receiving my second dose on April 23, 2021, the clogs worsened. Again, mostly the left breast, but occasionally on the right breast as well. They were almost continuous with only 12-24 hours of relief in between for 4-5 weeks after my second injection. After about a 5 week period after the second injection, the clogs lessened and eventually I no longer experienced regular recurring clogs.  No particular treatment helped (I tried all recommended methods to relieve a clogged duct), just time and continuous breastfeeding.   In total, the recurring bad clogs lasted about 11-12 weeks from the time of first vaccination.
Pt had slight pain and discovered pink rash about 11pm same day (11/26/01) 11/27 pain increased and redness increased 11/28 itching in red area, pain went to middle of forearm. 11/30 pain has dimished 75% itching has subsided but is still pink.
first shot .... I was ok for a while, when i went to bed that night i was dizzy ..when i woke up was a but dizzy .. but by 3 pm that next day I had virtago.. Very badly .. went to hosptial was checked for a stroke .. had bad virtago for 3 days ..   When I got my second shot i took motion sickness pills per my doctors instructions and was totally fine ... I did have covid a few weeks ago .. out of quartine on Dec 13 ... got my booster 12/29/2021 - took motion sickness pills prior to shot ... within 15 minutes i was a bit dizzy .. but ok ... 1 hour later .. very dizzy .. lips felt funny ... trouble thinking ... took montion sickness pills all day .. went to bed and 12/30/2021 feel fine - no dizziness ..
Swelling; This is a spontaneous report from a contactable pharmacist.   A patient of an unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) on an unspecified date, at single dose, for immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, after the vaccination, the patient experienced swelling. Clinical outcome of the adverse event was unknown at time of this report.   No follow-up attempts are needed, information about lot number cannot be obtained.
5 year old male with past medical with intermittent syncope (similar to today's event) presented for  second Pfizer vaccine. Evaluated two months ago in ED, discharged with recommendation to have patient evaluated by neurology. Evaluation has not taken place yet. Patient received initial vaccine on 1/10/22 without incident of note patient has not had similar episodes related to receiving vaccines.  Today, about 7:35pm received second vaccine In series. Initially child responded without incident Upon arriving for observation approximately one minute. No seizure activity noted. Patient easily aroused but groggy. NONE today. Previously had EKG performed in ER related to similar event.  Vital signs: BP=100/80, apical rate = 100, respiration easy, even, and unlabored, color rapidly return to normal. Patient remained lethargic for ten minutes. Slowly returned to normal upon standing and steady on feet. Color remained stable. Heart rate and respirations stable. After 15 minutes, child continued to be lethargic and fell  asleep. Parents reported 8-8:30pm is his bedtime. Discussed the lack of previous evaluation for similar events.  Discussed with the father via interpreter concerns for repeated syncopal episodes without being evaluated. Encouraged parents to have child transported to hospital for evaluation. Paramedics called. Arrived and evaluated patient. At 8:29pm, BP=116/93, HR=120, Blood glucose = 90. Dr notified. Discussed case and agrees with decision to have a child evaluated at the ER. Child became more responsive as parents tried to change his shirt but continued to be concerned regarding lack of previous evaluation of similar events. Patient left accompanied by mother and paramedics.
Student had gotten a flu vaccine on 10/30/20 from pharmacy. She came to the campus flu clinic on 1/26/21 and received another flu vaccine, her first dose being unbeknownst to the flu clinic staff.
Client receives Pfizer booster at 10:51 am, complains of throat closing and thick tongue at 11:13 am.  Denies shortness of breath or trouble breathing, states she feels anxious.  No facial swelling noted.  Vital signs stable.  Benadryl 50 mg IM given @ 11:18 am.  EMS called at 11:25.  EMS arrived on site @ 11:36 am, assumed care.  Client take to hospital by EMS @ 11:43 AM.
1. Fever 101.2. (Temp at 0900 prior to vaccine administration 97.3) 2. Shortness of Breath 3. O2 Sats less than 70 4. Second temperature reading 97.4 on same day
Pt received Gardasil injection. 10 minutes later proceeded to reception area to schedule next appointment and fainted.
she is now experiencing sciatic nerve problem; This is a spontaneous report from a Pfizer Sponsored program. A contactable consumer reported for a female patient (Sister in Law). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 01Feb2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that Husband (Name) and Sister-in-Law (Name) had their 1st dose (01Feb2021) and 2nd dose (24Feb2021) but sister-in-law can't make it today because she was now experiencing sciatic nerve problem, Caller was calling to report this and appoint/reschedule sister in law's 2nd dose. Their dosing schedules were more than the usual 3weeks interval. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
nasal dripping; burning in her nose; Drug ineffective; Covid 19 Infection positive after completing 2 doses; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid 19 Infection positive after completing 2 doses), RHINORRHEA (nasal dripping), NASAL DISCOMFORT (burning in her nose) and DRUG INEFFECTIVE (Drug ineffective) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 011M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced COVID-19 (Covid 19 Infection positive after completing 2 doses). On an unknown date, the patient experienced RHINORRHEA (nasal dripping), NASAL DISCOMFORT (burning in her nose) and DRUG INEFFECTIVE (Drug ineffective). At the time of the report, COVID-19 (Covid 19 Infection positive after completing 2 doses), RHINORRHEA (nasal dripping) and NASAL DISCOMFORT (burning in her nose) outcome was unknown and DRUG INEFFECTIVE (Drug ineffective) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-May-2021, SARS-CoV-2 test: positive (Positive) positive.         No concomitant medication were provided  Treatment medication was not provided  Action taken with mRNA-1273 Moderna vaccine was Not applicable   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received on 25-MAY-2021: Included No new information
1) Weird headaches started the following day after vaccination they were strong initially, but have let up. Blurred vision:  2) Vision started noticeably deteriorating since vaccination w/recent occasional flashes while eyes shut and dizziness. 3) Suspected Dupuytren's Contracture (two cysts on left hand with pain) appeared approximately 2 weeks post vaccination.  I have an appointment set with a hand surgeon next month for evaluation.